Continuous Glucose Monitoring in Prediabetes with Health Education Videos
Launched by DAVID S BLACK, PHD · Mar 12, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special system that continuously monitors blood sugar levels can help people with prediabetes improve their health. Participants will use a wearable device that tracks their glucose levels and receive feedback through their smartphones. They will also watch educational videos created with the help of artificial intelligence, aimed at teaching them how to manage their blood sugar better. The main goal of the trial is to help prevent participants from developing type 2 diabetes and related health issues.
To be eligible for the study, participants should be between 65 and 74 years old and have been diagnosed with prediabetes. They need to be willing to wear a continuous glucose monitor (CGM) device and have a compatible smartphone. However, people who are pregnant or have certain medical conditions that might affect their blood sugar levels cannot participate. Those who join the study can expect to learn more about their health while receiving support through the monitoring system and videos. This innovative approach aims to make managing prediabetes easier and more effective.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pre-diabetes determined by finger prick A1c% Willingness to wear a CGM sensor Community health worker
- Exclusion Criteria:
- • Currently pregnant Diagnosed with any disorder likely interfering with blood glucose levels Influential medical disorder or event affecting ability to participate in the study Incompatible smartphone device not pairing with the Dexcom CGM system
About David S Black, Phd
David S. Black, PhD, is a distinguished clinical trial sponsor with extensive expertise in the design and implementation of innovative research studies. With a strong background in behavioral science and health interventions, Dr. Black is committed to advancing medical knowledge and improving patient outcomes through rigorous clinical trials. His leadership in the field is characterized by a focus on evidence-based practices, collaboration with multidisciplinary teams, and adherence to ethical standards. Dr. Black's work not only contributes to the scientific community but also aims to translate research findings into practical applications that enhance healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
David S Black, PhD MPH
Principal Investigator
University of Southern California Keck School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported